Eli Lilly stock slips after hours as obesity-pill race stays in the spotlight
Eli Lilly shares fell 2.1% to $1,064.29 in after-hours trading Friday, following news that Novo Nordisk’s Wegovy pill logged 18,410 U.S. prescriptions in its first full week. Lilly will report fourth-quarter earnings on Feb. 4.